Announcements Trials
Browse Landscape

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 41Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Neoplasms 3Leukemia, Myeloid, Chronic-Phase 3Leukemia 3Gastrointestinal Stromal Tumors 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Hematologic Neoplasms 1GIST 1

Interventions

Psychiatric Rehabilitation 7Flow Cytometry 6Therapeutics 5Surveys and Questionnaires 5Microarray Analysis 5Gene Expression Profiling 5Vincristine 4Polymerase Chain Reaction 4Methotrexate 4Daunorubicin 4Cytogenetic Analysis 4Amplified Fragment Length Polymorphism Analysis 4ponatinib 3fludarabine 3Watchful Waiting 3Prednisone 3Observation 3Mercaptopurine 3Interviews as Topic 3Inotuzumab Ozogamicin 3Immunologic Techniques 3Immunoenzyme Techniques 3Cytarabine 3Cyclophosphamide 3tisagenlecleucel 2pegaspargase 2fish oil triglycerides 2blinatumomab 2In Situ Hybridization, Fluorescence 2Imatinib Mesylate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Imatinib Mesylate × Clear all
NCT06175702 2023-12-19

LALPh2022

PETHEMA Foundation

Not yet recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03331211 2017-11-08

Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia

Nanfang Hospital, Southern Medical University

Unknown
100 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡